These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Heterologous protein production by filamentous fungi. Jeenes DJ; Mackenzie DA; Roberts IN; Archer DB Biotechnol Genet Eng Rev; 1991; 9():327-67. PubMed ID: 1839127 [TBL] [Abstract][Full Text] [Related]
4. [Recombinant plasma proteins for therapeutic use--status and developmental trends]. Storch H Beitr Infusionsther; 1993; 31():31-7. PubMed ID: 7693261 [TBL] [Abstract][Full Text] [Related]
6. Yeast systems biotechnology for the production of heterologous proteins. Graf A; Dragosits M; Gasser B; Mattanovich D FEMS Yeast Res; 2009 May; 9(3):335-48. PubMed ID: 19341379 [TBL] [Abstract][Full Text] [Related]
7. Biotechnology: alternatives to human plasma-derived therapeutic proteins. Lynch TJ Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):669-88. PubMed ID: 11102283 [TBL] [Abstract][Full Text] [Related]
8. Cell-free expression systems for eukaryotic protein production. Endo Y; Sawasaki T Curr Opin Biotechnol; 2006 Aug; 17(4):373-80. PubMed ID: 16828277 [TBL] [Abstract][Full Text] [Related]
9. Production of heterologous proteins in plants: strategies for optimal expression. Desai PN; Shrivastava N; Padh H Biotechnol Adv; 2010; 28(4):427-35. PubMed ID: 20152894 [TBL] [Abstract][Full Text] [Related]
10. Viral infectivity of albumin and plasma protein fraction. Erstad BL Pharmacotherapy; 1996; 16(6):996-1001. PubMed ID: 8947970 [TBL] [Abstract][Full Text] [Related]
11. Recombinant protein production in yeasts. Mattanovich D; Branduardi P; Dato L; Gasser B; Sauer M; Porro D Methods Mol Biol; 2012; 824():329-58. PubMed ID: 22160907 [TBL] [Abstract][Full Text] [Related]
12. Recombinant antithrombin: production and role in cardiovascular disorder. Levy JH; Weisinger A; Ziomek CA; Echelard Y Semin Thromb Hemost; 2001 Aug; 27(4):405-16. PubMed ID: 11547363 [TBL] [Abstract][Full Text] [Related]
13. Production of recombinant proteins and metabolites in yeasts: when are these systems better than bacterial production systems? Porro D; Gasser B; Fossati T; Maurer M; Branduardi P; Sauer M; Mattanovich D Appl Microbiol Biotechnol; 2011 Feb; 89(4):939-48. PubMed ID: 21125266 [TBL] [Abstract][Full Text] [Related]
14. Quality assessment of recombinant proteins produced in plants. Medrano G; Dolan MC; Condori J; Radin DN; Cramer CL Methods Mol Biol; 2012; 824():535-64. PubMed ID: 22160919 [TBL] [Abstract][Full Text] [Related]
15. Biotechnology and the plasma fractionation industry--the impact of advances in the production of coagulation factor VIII. Farrugia A Australas Biotechnol; 1993; 3(1):16-20. PubMed ID: 7763537 [TBL] [Abstract][Full Text] [Related]
16. The dynamics of contract plasma fractionation. Farrugia A; Scaramuccia D Biologicals; 2017 Mar; 46():159-167. PubMed ID: 28236560 [TBL] [Abstract][Full Text] [Related]
17. Summary of recombinant human serum albumin development. Kobayashi K Biologicals; 2006 Mar; 34(1):55-9. PubMed ID: 16464610 [TBL] [Abstract][Full Text] [Related]
18. Vitamin K-dependent protein production in transgenic animals. LuboĊ H; Paleyanda RK Thromb Haemost; 1997 Jul; 78(1):532-6. PubMed ID: 9198210 [TBL] [Abstract][Full Text] [Related]
19. Recombinant protein production in transgenic animals. Echelard Y Curr Opin Biotechnol; 1996 Oct; 7(5):536-40. PubMed ID: 8939621 [TBL] [Abstract][Full Text] [Related]
20. Recombinant expression systems for the production of collagen. Bulleid NJ; John DC; Kadler KE Biochem Soc Trans; 2000; 28(4):350-3. PubMed ID: 10961917 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]